Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis - Quiz - MDSpire

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis

  • By

  • Wei Kang

  • Bowie P. Y. Lam

  • Rinko Tsz Lam Lau

  • Silvia T. H. Li

  • Kangrui Wu

  • Yue Wei

  • Yu Yang

  • Kyung Jin Lee

  • Caige Huang

  • Vincent K. C. Yan

  • Hei Hang Edmund Yiu

  • Shing Fung Lee

  • Aya El Helali

  • Victor H. F. Lee

  • Stephen L. Chan

  • Rina Y. M. Hui

  • Ka On Lam

  • Esther W. Chan

  • June 15, 2026

  • 0 min

Share

Original Source(s)

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis

  • by Wei Kang, Bowie P. Y. Lam, Rinko Tsz Lam Lau, Silvia T. H. Li, Kangrui Wu, Yue Wei, Yu Yang, Kyung Jin Lee, Caige Huang, Vincent K. C. Yan, Hei Hang Edmund Yiu, Shing Fung Lee, Aya El Helali, Victor H. F. Lee, Stephen L. Chan, Rina Y. M. Hui, Ka On Lam, Esther W. Chan

  • June 15, 2026

Related Content

2026 AACR Renal Cell Carcinoma Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the renal cell carcinoma clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min
Intracranial mesenchymal tumor with FET::CREB fusion: a rare case report

An IHC-derived TLS–CD8–macrophage immune niche score predicts major pathological response to neoadjuvant chemoimmunotherapy in resectable NSCLC